S&P 500   2,966.15 (-0.14%)
DOW   26,787.36 (-0.11%)
QQQ   191.09 (-0.01%)
AAPL   235.87 (-0.14%)
FB   183.28 (-0.49%)
MSFT   139.55 (-0.09%)
GOOGL   1,217.77 (+0.17%)
AMZN   1,736.43 (+0.26%)
CGC   18.86 (-2.93%)
NVDA   186.53 (+0.29%)
MU   44.86 (-0.53%)
BABA   171.16 (-1.03%)
GE   8.72 (-0.91%)
TSLA   256.96 (+3.66%)
AMD   30.53 (+2.62%)
T   37.47 (-0.29%)
F   8.82 (+0.46%)
ACB   3.51 (-4.62%)
PRI   121.47 (-0.18%)
NFLX   285.53 (+0.92%)
BAC   29.14 (+0.80%)
GILD   64.51 (+0.81%)
DIS   129.70 (-0.25%)
S&P 500   2,966.15 (-0.14%)
DOW   26,787.36 (-0.11%)
QQQ   191.09 (-0.01%)
AAPL   235.87 (-0.14%)
FB   183.28 (-0.49%)
MSFT   139.55 (-0.09%)
GOOGL   1,217.77 (+0.17%)
AMZN   1,736.43 (+0.26%)
CGC   18.86 (-2.93%)
NVDA   186.53 (+0.29%)
MU   44.86 (-0.53%)
BABA   171.16 (-1.03%)
GE   8.72 (-0.91%)
TSLA   256.96 (+3.66%)
AMD   30.53 (+2.62%)
T   37.47 (-0.29%)
F   8.82 (+0.46%)
ACB   3.51 (-4.62%)
PRI   121.47 (-0.18%)
NFLX   285.53 (+0.92%)
BAC   29.14 (+0.80%)
GILD   64.51 (+0.81%)
DIS   129.70 (-0.25%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 22nd Century GroupEmerald Health TherapeuticsPfenexBotanix PharmaceuticalsEmblem
SymbolNYSEAMERICAN:XXIICVE:EMHNYSEAMERICAN:PFNXASX:BOTN/A
Price Information
Current Price$1.99C$1.00$8.96A$0.25N/A
52 Week RangeBuyHoldBuyN/AN/A
Analyst Ratings
Consensus RecommendationBuyHoldBuyN/AN/A
Consensus Price Target$12.00C$1.50$17.00N/AN/A
% Upside from Price Target503.02% upside50.00% upside89.73% upsideN/AN/A
Trade Information
Market Cap$256.36 millionC$149.44 million$280.59 million$236.30 million$248.31 million
BetaN/AN/AN/AN/AN/A
Average Volume1,434,193624,499206,4364,450,000865,800
Sales & Book Value
Annual RevenueN/AC$8.04 millionN/A$4.69 million$5.71 million
Price / SalesN/A18.59N/A50.430.00
CashflowN/AC$0.02 per shareN/AA$0.01 per shareN/A
Price / CashN/A58.82N/A48.004.08
Book ValueN/AC$1.33 per shareN/AA$0.00 per share$0.67 per share
Price / BookN/A0.75N/A245.000.00
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSN/AC($0.16)N/AA($0.02)($0.19)
Trailing P/E Ratio0.00N/A0.00N/AN/A
Forward P/E RatioN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AN/A$0.46
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A4.79%N/AN/A30.01%
Current RatioN/A0.92%N/A1.13%3.61%
Quick RatioN/A0.42%N/A1.13%3.24%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees821137110N/A
Shares Outstanding125.66 million149.44 million31.60 million964.50 million132.08 million
Next Earnings Date11/6/2019 (Estimated)N/A11/6/2019 (Estimated)N/AN/A
OptionableOptionableNot OptionableOptionableNot OptionableNot Optionable
 22nd Century GroupEmerald Health TherapeuticsPfenexBotanix PharmaceuticalsEmblem

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel